ROC analysis revealed that the CSF CXCL13 levels were robust in discriminating patients with neurosyphilis and non-neurosyphilis/syphilis, with an AUC of 0.831 (95 % CI 0.724–0.938, P = 0.000). This evidence concerns the gene CXCL13 and neurosyphilis.